CYBERDYNE Inc. (JP:7779)
:7779
Want to see JP:7779 full AI Analyst Report?
Top Page
CYBERDYNE
(7779)
Select Model
Select Model
Rating:53Neutral
Price Target:
¥250.00
▲(15.74% Upside)
Action:Reiterated
Date:06/05/26
The score is driven primarily by improved but still uneven fundamentals: a strong, low-debt balance sheet and a better latest year for net income/free cash flow are offset by ongoing operating losses and historically volatile cash generation. Technically, the stock trends above key moving averages but momentum is not fully confirmed. Valuation is the main drag given the extremely high P/E and no dividend support.
Positive Factors
Balance Sheet Strength
Very low leverage and a sizable equity base give CYBERDYNE durable financial flexibility: less refinancing risk, capacity to fund clinical deployments, R&D and support services, and resilience through reimbursement or adoption cycles. This structural conservatism underpins long-term optionality.
Negative Factors
Persistent Operating Losses
Despite recent net income, the core business still records recurring operating losses and negative EBITDA. This structural unprofitability implies reliance on one-off items or non-operating gains to post net profits, challenging the company’s ability to generate sustainable operating earnings as it scales.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
Very low leverage and a sizable equity base give CYBERDYNE durable financial flexibility: less refinancing risk, capacity to fund clinical deployments, R&D and support services, and resilience through reimbursement or adoption cycles. This structural conservatism underpins long-term optionality.
Read all positive factors
CYBERDYNE (7779) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥51.94B
Dividend YieldN/A
Average Volume (3M)724.97K
Price to Earnings (P/E)357.5
Beta (1Y)0.81
Revenue Growth-12.27%
EPS GrowthN/A
CountryJP
Employees227
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)0.72
Shares Outstanding137,445,820
10 Day Avg. Volume764,380
30 Day Avg. Volume724,970
Financial Highlights & Ratios
PEG Ratio-2.89
Price to Book (P/B)1.40
Price to Sales (P/S)14.44
P/FCF Ratio305.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥400.00Price Target Upside85.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.03
Revenue Forecast (FY)¥4.72B
CYBERDYNE Business Overview & Revenue Model
Company Description
Headquartered in Tsukuba, Japan, and founded in 2004, CYBERDYNE Inc. is dedicated to the ongoing research, development, production, sales, leasing, and maintenance of sophisticated equipment and systems, primarily for the medical and defense secto...
How the Company Makes Money
CYBERDYNE generates revenue primarily by providing its HAL wearable exoskeleton systems and related services to customers in healthcare, rehabilitation, and care environments. Key revenue streams include (1) the sale and/or provision of HAL units ...
CYBERDYNE Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
78
Positive
Cash Flow
52
Neutral
| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.85B | 4.38B | 4.35B | 3.29B | 2.15B |
| Gross Profit | 2.27B | 2.07B | 2.03B | 1.49B | 1.25B |
| EBITDA | -489.00M | -904.00M | -1.06B | -722.00M | -565.00M |
| Net Income | 153.00M | -577.00M | -1.48B | -298.00M | -498.00M |
Balance Sheet | |||||
| Total Assets | 49.08B | 48.55B | 50.00B | 50.19B | 49.47B |
| Cash, Cash Equivalents and Short-Term Investments | 8.99B | 6.82B | 5.16B | 7.80B | 20.83B |
| Total Debt | 767.00M | 434.00M | 632.00M | 669.00M | 575.00M |
| Total Liabilities | 9.47B | 8.95B | 9.52B | 8.20B | 6.02B |
| Stockholders Equity | 39.62B | 39.58B | 40.75B | 42.10B | 43.41B |
Cash Flow | |||||
| Free Cash Flow | 182.00M | -726.00M | -1.07B | -594.00M | -2.33B |
| Operating Cash Flow | 195.00M | -430.00M | -850.00M | -143.00M | -564.00M |
| Investing Cash Flow | 2.09B | 2.33B | -2.08B | 2.17B | -1.79B |
| Financing Cash Flow | -205.00M | -216.00M | 160.00M | 14.00M | 1.25B |
CYBERDYNE Technical Analysis
Negative
216.00
Price Trends
290.26
Negative
299.21
Negative
245.38
Positive
Market Momentum
-10.25
Positive
37.27
Neutral
7.72
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7779, the sentiment is Negative. The current price of 216 is below the 20-day moving average (MA) of 285.40, below the 50-day MA of 290.26, and below the 200-day MA of 245.38, indicating a neutral trend. The MACD of -10.25 indicates Positive momentum. The RSI at 37.27 is Neutral, neither overbought nor oversold. The STOCH value of 7.72 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7779.
CYBERDYNE Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥10.08B | 14.02 | ― | 3.52% | 3.67% | -30.85% | |
67 Neutral | ¥8.37B | 10.86 | ― | 1.89% | 6.09% | -6.33% | |
61 Neutral | ¥227.14B | 15.43 | ― | 1.92% | 4.29% | 3.92% | |
54 Neutral | ¥24.18B | 90.23 | ― | 3.12% | -4.77% | ― | |
53 Neutral | ¥51.94B | 357.50 | -0.46% | ― | -12.27% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | ¥132.79B | 269.18 | 2.42% | 3.73% | 0.78% | -95.37% |
* Healthcare Sector Average
JP:7779
CYBERDYNE
246.00
75.00
43.86%
JP:6523
PHC Holdings Corp.
1,043.00
213.63
25.76%
JP:5187
Create Medic Co., Ltd.
1,108.00
191.53
20.90%
JP:6849
Nihon Kohden Corporation
1,385.50
-280.45
-16.83%
JP:7600
Japan Medical Dynamic Marketing, Inc.
918.00
374.44
68.89%
JP:7963
Koken Ltd.
1,702.00
-14.12
-0.82%
CYBERDYNE Corporate Events
Cyberdyne Launches Global VC Alliance to Drive Physical AI and Cybernics Growth
Jun 1, 2026
Cyberdyne has formed a strategic business alliance with Silicon Valley-based venture capital firm Pegasus Tech Ventures to accelerate business creation and global expansion in its “HCPS Cybernics with Physical AI” domain. By tapping Pe...
CYBERDYNE Swings to Profit Despite Revenue Dip and Maintains Strong Balance Sheet
May 14, 2026
CYBERDYNE reported a 12.3% year-on-year decline in revenue to ¥3.85 billion for the fiscal year ended March 31, 2026, but significantly improved profitability, moving from a loss attributable to owners of ¥577 million in the previous yea...
CYBERDYNE Extends SIP Smart Mobility R&D Contract and Increases Project Funding
Mar 26, 2026
CYBERDYNE Inc. has amended its business consignment agreement under Japan’s Cross-ministerial Strategic Innovation Promotion Program, Third Phase, for the development of a smart mobility platform. The project targets Theme 12, which focuses ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.